1.-Alberti KGMM, Zimmet P, DeFRonzo RA. Textbook .Diabetes
Mellitus (2ª ed.). Wiley, Chichester, 1997.
2.-American Diabetes Association. Consensus Development Conference
on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998;
21: 1551-1559
3.-American Diabeters Association. Clinical Practice Recommendations
2000. Diabetes Care 2000; 23 (suppl. 1) :S1-S112.
4.-Ballantyne CM, Grundy SM, Oberman A, Kreisberg RA, Havel RJ,
Frost PH, et al. Hyperlipidemia: Diagnostic and therapeutic perspectives. J Clin
Endocrinol Metab 2000; 85: 2089-2112.
5.-Coutinho M, Gerstein WC, Wang Y, Yusuf S. The relationship
between glucose and incident cardiovascular events. A metaregression analysis of published
data from 20 studies of 95.783 individuals. Diabetes Care 1999; 22: 233-240.
6.-DCCT Research Group. The effect of intensive treatment of
diabetes on the development and progression of long-term complications in insulin
dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
7.-DeFronzo RA. Current therapy of diabetes mellitus. Mosby, St.
Louis, 1998.
8.- European Diabetes Policy Group 1999. A desktop guide to type 2
diabetes mellitus. Diabet Med 1999; 16: 716-730.
9.-.Laakso M. Letho S. Epidemiology of macrovascular disease in
diabetes. Diabetes Reviews 1997; 5: 294-315.
10.-Lebovitz HE. Therapy for diabetes mellitus and related
disorders. (3ª ed.).American Diabetes Association.Alexandria, 1998.
11.-LeRoith D, Taylor SI, Olefsky JM. Diabetes mellitus (2ª
ed.)Philadelphia, Lippincot Williams & Wilkins, 2000
12.-Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenström A, Wedel
H of the DIGAMI Study Group. Effects of insulin treatment on cause-specific one-year
mortality and morbidity in diabetic patients with acute miocardial infarction. Eur Heart J
1996; 17: 1337-1344.
13.-Pallardo L.F. Tratamiento insulinico Medicine 2000; 8 (20):
1047-1053.
14.-Pickup J, Williams G. Textbook of Diabetes (2ª ed.). Oxford,
Blackwell Science, 1997
15.-Prevention of diabetes mellitus. Report of a WHO Study Group.
WHO Technical Report Series 844. World Health Organization. Geneva, 1994.
16.-Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ,
Bouter LM. Insulin and risk of cardiovascular disease. A meta-analysis . Circulation 1998;
97: 996-1001.
17.-The Expert Committee on the Diagnosis and Classification of
Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of
Diabetes Mellitus. Diabetes Care,1997; 20: 1183-1197.
18.-The Heart Outcomes Prevention Evaluation (HOPE) Sudy
Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people
with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;
355: 253-259.
19.-The Sixth Report of the Joint National Committee on Prevention,
Detection, Evaluation and Treatment of High Blood Pressure. Arch. Intern Med 1997; 157:
2413-2446.
20.-UK Prospective Diabetes Study Group. Intensive blood-glucose
control with sulphonylureas or insulin compared with conventional treatment and risk of
complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
21.- UK Prospective Diabetes Study Group. Effect of intensive
blood-glucose with metformin on complications in overweight patients with type 2 diabetes
(UKPDS 34). Lancet 1998; 352: 854-865.
22.- UK Prospective Diabetes Study Group.Tight blood pressure
control and risk of macrovascular and microvascular complications in type 2 diabetes
(UKPDS 38). Br Med J 1998; 317: 703-713.
